A study identified an accurate approach to measuring disease activity in patients with systemic lupus erythematosus (SLE), which is crucial for clinical management.
Revenue for the year ended December 31, 2025 was $81,835,279, compared to $27,770,280 in 2024, representing growth of 195% ...
Objective Biomarkers and FDA-Cleared Tools While existing tools represent decades of clinical and research development, they ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...
The Environmental Protection Agency is reconsidering whether facilities that recycle plastic chemically should be held to the ...
STEM Education approach can be applied in schools through various practical activities involving experiments, simulations, ...
Researchers from the Department of Energy's Quantum Science Center (QSC) headquartered at Oak Ridge National Laboratory (ORNL ...
Tuesday, June 17, 2025 at 8:30 a.m. ET. CALL PARTICIPANTS. Chief Executive Officer — Brendan L. Hoffman; Chief Financial ...
The Environmental Protection Agency is reconsidering whether facilities that recycle plastic chemically should be held to the ...
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, ...
Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biolog ...
Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...